Literature DB >> 1918460

Occurrence of other malignancies in 1973 patients with basal cell carcinoma.

B Lindelöf1, B Sigurgeirsson, P Wallberg, G Eklund.   

Abstract

To evaluate the possible association of other malignancies with basal cell carcinoma, we reviewed 1973 consecutive patients with basal cell carcinoma. We searched the Swedish Cancer Registry for records reporting malignancies in the study population (1958-1984) and the expected number of malignancies was calculated on the basis of age- and sex-standardized incidence data. In 452 patients with basal cell carcinoma another malignancy was diagnosed. The expected number was 323 (relative risk = 1.4; 95% confidence interval = 1.3 to 1.5). A significant association with basal cell carcinoma was found in four cancer types for men and in three for women. For skin malignancies other than malignant melanoma there was more than a sixfold increased risk for men (relative risk = 6.8; 95% confidence interval = 4.8 to 9.4) and more than a threefold increased risk for women (relative risk = 3.1; 95% confidence interval = 1.4 to 5.9) during the period after the diagnosis of basal cell carcinoma. During the period before the diagnosis of basal cell carcinoma, there were also increased risks (men: relative risk = 5.0; 95% confidence interval = 3.1 to 7.5; women: relative risk = 4.0; 95% confidence interval = 1.9 to 7.4). This was in contrast to the risks of malignant melanoma. Before the diagnosis of basal cell carcinoma there was no significant increased risk of malignant melanoma but after the diagnosis there was more than a sixfold increased risk for men (relative risk = 6.8; 95% confidence interval = 4.8 to 9.4) and more than a fourfold increased risk for women (relative risk = 4.2; 95% confidence interval = 1.5 to 9.2).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1918460     DOI: 10.1016/0190-9622(91)70189-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  12 in total

Review 1.  Basal cell carcinoma.

Authors:  J T Lear; I Harvey; D de Berker; R C Strange; A A Fryer
Journal:  J R Soc Med       Date:  1998-11       Impact factor: 5.344

Review 2.  Basal cell carcinoma.

Authors:  C S M Wong; R C Strange; J T Lear
Journal:  BMJ       Date:  2003-10-04

3.  The frequency of self-skin examination and full body skin examination in dermatologists.

Authors:  Peter Saitta; David E Cohen; Darrell Rigel; Steven K Grekin; Ronald Brancaccio
Journal:  J Clin Aesthet Dermatol       Date:  2011-06

4.  Creation of a quality of life instrument for nonmelanoma skin cancer patients.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Mary Burzynski; Ann B Nattinger
Journal:  Laryngoscope       Date:  2005-07       Impact factor: 3.325

5.  Is a personal history of nonmelanoma skin cancer associated with increased or decreased risk of other cancers?

Authors:  Anthony J Alberg; Alexander H Fischer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03       Impact factor: 4.254

Review 6.  Basal cell carcinoma.

Authors:  J T Lear; A G Smith
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

Review 7.  Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review.

Authors:  Lee Wheless; Joshua Black; Anthony J Alberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-22       Impact factor: 4.254

8.  Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis.

Authors:  Margaret R Karagas; Janet L Peacock; Judy R Rees; M Scot Zens; Maria O Celaya; Bruce L Riddle
Journal:  Int J Cancer       Date:  2015-01-29       Impact factor: 7.396

9.  Behavior modification and risk perception in patients with nonmelanoma skin cancer.

Authors:  John S Rhee; Melinda Davis-Malesevich; Brent R Logan; Marcy Neuburg; Mary Burzynski; Ann B Nattinger
Journal:  WMJ       Date:  2008-04

10.  Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational study.

Authors:  Mary Pressler; Carol A Rosenberg; Benjamin A Derman; Philip Greenland; Janardan Khandekar; Rebecca J Rodabough; Anne McTiernan; Michael S Simon
Journal:  Breast Cancer Res Treat       Date:  2013-06-13       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.